• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASMQ Launch

27 April 2008

Rio de Janeiro, Brazil

Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.

PRESENTATIONS

First Session – Status of Implementation and R&D of Artemisinin-based Combination Therapies (ACTs) (Bernard Pécoul/Drugs for Neglected Diseases initiative – DNDi, Switzerland)

Rationale for ACTs [311KB]

(Piero Olliaro/ Special Programme for Research and Training in Tropical Diseases – TDR, Switzerland) [English]

Status of R&D Portfolio for New Malaria Treatments [477KB]
(J. Carl Craft/Medicines for Malaria Venture – MMV, Switzerland) [English]

Status of ACTs Implementation in Latin America [3.7MB]
(Roberto Montoya/Pan American Health Organization – PAHO, Brazil) [Portuguese/Spanish]

Status of ACTs Implementation in Brazil [414KB]
(José Lázaro de Brito Ladislau/National Program of Malaria Control/ Ministry of Health – PNCM/ MoH, Brazil) [Portuguese]

Second Session – Development of ASMQ combination (Carlos Morel/Fiocruz, Brazil)

FACT: An Innovative Partnership [703KB]
(Jean-René Kiechel/ DNDi, Switzerland) [English]

ASMQ Product Profile: From Blue Print to Blue Pill [2.1MB]
(Jorge Mendonça, Alessandra Viçosa, Luciana Gonçalves and Érico Daemon/ Farmanguinhos – Fiocruz, Brazil) [Portuguese/English]

Pharmacokinetics in Healthy Normal Volunteers and Patients [148KB]
(Michel Vaillant /CRP Santé Luxembourg) [English]

Phase III and Field Studies [1.1MB]
(François Nosten/Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Elizabeth Ashley [English]

Third Session – Clinical Studies (Piero Olliaro/TDR, Switzerland)

Status of Clinical Studies in Thailand [884KB]
(François Nosten/ Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Julien Zwang [English]

Status of Clinical Studies in Peru [1.15MB]
(Cristiam Angeles/ Loreto Regional Health Directorate, Peru) [Spanish]

Status of Clinical Studies in Brazil: State of Acre [7.4MB]
(Marize Lucena, Health Surveillance Secretariat – State of Acre; Ana Carolina Santelli/PNCM – MoH, Brazil) [Portuguese]

Status of Clinical Studies in Tanzania: African Perspective [116KB]
(Andrew Kitua/National Institute for Medical Research – NIMR, Tanzania) [English]

Other Planned Clinical Studies, including India and Myanmar
(Isabela Ribeiro/ DNDi, Brazil) [English]

Other events

Loading...
26 February 2026

Berlin, Germany

From discovery to delivery: Advancing care for neglected tropical diseases

23-24 February 2026

Bonn, Germany

DZIF/PEG Joint Meeting 2026

10-13 February 2026

Nairobi, Kenya

16th KASH conference

30 January 2026

Online

Bridging gaps in neglected tropical diseases data

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license